Pharmaceutical Executive-03-01-2020

Pharmaceutical Executive

Consider Data Before It’s a Problem

March 11, 2020

From the Editor

40

3

Amid concerns over a potential 'wild west' climate for data analytics in pharma, taking a long-term, proactive, and enterprise view of your company’s data may be the best way to keep your organization and reputation safe.

Blood Feud Divides Europe Over Plasma Shortfalls

March 09, 2020

Columns

40

3

The collection of source plasma for new therapies igniting debate.

Habib Bennaceur: Following the Science

March 07, 2020

Features

40

3

AstraZeneca’s Habib Bennaceur talks about the key transitions in his career-from local to global-and his current role in positioning AZ’s Farxiga as a drug with the potential to impact the lives of both patients with and without type 2 diabetes.

Pharmaceutical Executive, March 2020 Issue (PDF)

March 01, 2020

Issue PDF

40

3

Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.

Country Report: United Arab Emirates

March 01, 2020

Special Sponsored Section

40

3

With an estimated annual growth rate of 10%, the Middle East is now consistently outpacing traditionally sought-after “pharmerging” heavyweights such as China and Brazil. The United Arab Emirates is at the center of this newfound momentum-asserting its own credentials as a prospective destination for big-ticket foreign investment in healthcare.